No menu items!

Survey: 46.9 Percent of Brazilians Prefer to Wait for Results on Efficacy Before Vaccination

RIO DE JANEIRO, BRAZIL - Brazilians are split on a potential vaccine against Covid-19, according to a survey by the National Confederation of Transports (CNT) with the MDA Institute published on Monday, October 26th. The survey shows that 46.9 percent of respondents would rather wait for results in other people to then be vaccinated. On the other hand, 40.8 percent want to be immunized as soon as possible.

AstraZeneca pharmaceutical company announced that the vaccine against Covid-19 developed by Oxford University produces a similar immune response in older and younger adults and has minor adverse reactions among . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content